Literature DB >> 31778371

Influential factors in patient uptake of influenza vaccination during pregnancy; a survey-based audit in a tertiary hospital setting.

Kristin Andre1, Vesko Gavrilov1, Sarah Graham1, Simon M Scheck2, Anita Chandler1, Katie Hunter3, Rebecca Crabbe2, Daisy Wildash1, Paul Canning2, Sam Lepine4.   

Abstract

AIM: The aim of this study was to determine the key influential factors for pregnant or recently pregnant women in deciding on influenza vaccination.
METHOD: This study was conducted in a single tertiary hospital in New Zealand using an anonymous and voluntary patient survey. Ethnicity, age and stage of pregnancy along with self-reported data on factors that influenced the decision to vaccinate against influenza during pregnancy were recorded.
RESULTS: We included 101 participants over the one-week study period, 76% of whom had received the influenza vaccination. The most commonly reported reason for vaccination was the desire for neonatal protection, the common reasons for not being vaccinated were not receiving information on vaccination or safety concerns.
CONCLUSION: There are a variety of factors influencing women when deciding on antenatal influenza vaccination. Further studies are needed to expand on the findings of this small local study in order to be able to improve vaccination uptake through empathetic delivery of evidence-based recommendations.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31778371

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  2 in total

Review 1.  RSV Prevention in All Infants: Which Is the Most Preferable Strategy?

Authors:  Susanna Esposito; Bahaa Abu Raya; Eugenio Baraldi; Katie Flanagan; Federico Martinon Torres; Maria Tsolia; Stefan Zielen
Journal:  Front Immunol       Date:  2022-04-28       Impact factor: 8.786

Review 2.  Barriers and Facilitators Associated With Vaccine Acceptance and Uptake Among Pregnant Women in High Income Countries: A Mini-Review.

Authors:  Xiao Qiu; Heather Bailey; Claire Thorne
Journal:  Front Immunol       Date:  2021-04-26       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.